We show that in the rat, the major gene of PNS myelin, P 0 , is expressed long before myelination in the neural crest, Schwann cell precursors, and embryonic Schwann cells irrespective of whether they will myelinate or not. This myelin-independent P 0 expression is constitutive and likely to serve as a specific marker for the Schwann cell lineage. The much higher P 0 expression accompanying myelination is therefore not new gene expression but strong up-regulation of preexisting basal levels. We provide new evidence that the up-regulation to myelination-related levels depends on positive extrinsic signals and therefore does not represent a constitutive phenotype. P 0 mRNA is not detectable in mature non-myelin-forming Schwann cells of the sympathetic trunk, but is detectable after transection, indicating that there is a P 0 -inhibitory signal associated with mature unmyelinated axons. Thus, the regulation of the P 0 gene is complex, encompassing extrinsically signaled amplification superimposed on a highly lineage-specific and constitutive basal expression.
INTRODUCTION
The formation of a myelin sheath by Schwann cells is a particularly striking example of an inductive cell-cell interaction in which one cell, in this case the neuron, reversibly alters the phenotype of its neighbor, the Schwann cell (Bray et al., 1981; Mirsky and Jessen, 1996) . The major protein of PNS myelin, P 0 , constitutes about 50% of the total myelin protein and, acting via homophilic interactions, has a major role in stabilizing the myelin sheath (Lemke and Axel, 1985; D'Urso et al., 1990; Filbin et al., 1990; Giese et al., 1992) . Myelinforming cells gradually deposit very large amounts of P 0 in the myelin sheath, and the relative abundance of P 0 mRNA rises about 30-to 40-fold from birth to its peak in actively myelinating nerves, while it falls to lower, stable levels in adult nerves (Lemke and Axel, 1985; Trapp et al., 1988; Stahl et al., 1990) . Clearly, elucidation of the mechanisms that regulate P 0 gene expression is an important step toward understanding the cellular signaling that directs myelination.
Historically, three observations have had major impact in this area. First, isolation of Schwann cells from axons prior to myelination prevents the striking increase in P 0 expression seen when Schwann cells myelinate, suggesting that expression of myelin proteins is induced by positive axon-associated signals and does not represent a default state (Mirsky et al., 1980) . Second, removal of myelin-forming cells in developing or adult nerves from contact with axons by nerve transection results in a rapid reduction of P 0 expression, indicating that axonal induction of the P 0 gene remains reversible and that the presence of these signals is therefore required long term (Trapp et al., 1988) . Third, P 0 gene expression in Schwann cells has not been detected 1 These authors contributed equally to this work.
significantly before myelination starts in rodents, nor has P 0 been found in postnatal non-myelin-forming cells, suggesting that P 0 expression during myelination represents new gene expression specific to myelinforming cells (e.g., Baron et al., 1994) .
It is timely to reevaluate this picture of P 0 regulation, to take account of recent work, such as the finding that P 0 expression can be negatively regulated (for Refs. see below) and also to incorporate important but relatively neglected older observations. Thus, it has been known for some time that although P 0 levels fall sharply in transected adult nerves, a low but significant amount of P 0 mRNA and protein remains (Poduslo et al., 1985; LeBlanc and Poduslo, 1990) . This points to two modes of regulation, an extrinsically signaled, high expression superimposed on an intrinsically controlled constitutive baseline, although this matter has not been systematically investigated further. Intriguingly, P 0 is expressed in the chick neural crest and P 0 mRNA has been detected by the polymerase chain reaction (PCR) in whole rat embryos at Embryo Day 14 (E14) (Bhattacharyya et al., 1991; Zhang et al., 1995) . This leaves open the fundamental question of when and in which cells P 0 gene expression starts in mammalian glial cell development, particularly in light of recent findings that peripheral myelin proteins or alternatively spliced forms of them can be found outside the glial lineage (Pribyl et al., 1993; Parmantier et al., 1995) . Last, there is evidence that P 0 gene expression can be suppressed as well as induced by cell-extrinsic signals. The first factor shown to have this effect was serum which caused a dose-dependent suppression of cAMP-induced P 0 protein expression (Morgan et al., 1991) and similar effects have since been seen with fibroblast growth factor-2 (FGF2) , transforming growth factor-b (TGFb) (Mews and Meyer, 1993; Morgan et al., 1994) , and neuregulin (Cheng and Mudge, 1996) . Most strikingly, in cocultures of neurons and Schwann cells, TGFb suppresses high P 0 expression and blocks myelination of axons, but allows formation of the normal mature relationship between unmyelinated axons and non-myelin-forming Schwann cells (Einheber et al., 1995; Guénard et al., 1995) . Together these observations open the possibility that axonal suppression of P 0 expression is a part of the developmental repertoire. There has, however, been no description of such inhibitory effects of axons in normal Schwann cell development. The most radical interpretation of these studies of P 0 inhibition has been proposed by Cheng and Mudge (1996) who question the idea that the sharply elevated P 0 expression commencing around birth in actively myelinating cells is driven by positive axonal signals, and suggest instead that myelination-related levels of P 0 expression represent the constitutive state which, prior to myelination, is suppressed by inhibitory signals.
In this paper we have examined most of the issues raised above. In contrast to previous observations on rodents, we find P 0 mRNA in a population of migrating neural crest cells, and show that it is also present in Schwann cell precursors from E14 nerves and in embryonic Schwann cells prior to myelination, provided the assay is adjusted to higher sensitivity than that needed to detect P 0 in myelin-forming cells in vivo. This expression in embryonic Schwann cells is irrespective of whether the cells will subsequently myelinate or develop along the nonmyelin pathway. Myelin-independent P 0 expression can also be detected at the protein level raising the possibility that P 0 has a role in cell-cell interactions in early glial development. Postnatally, the relative abundance of P 0 mRNA and protein is sharply elevated in the cells that myelinate, while cells not engaged in myelination continue to express basal levels of P 0 mRNA and protein initially, although P 0 mRNA subsequently falls to undetectable levels in mature non-myelin-forming cells, indicating the existence of suppressive signals in vivo. We show that the basal P 0 expression is constitutive, in the sense that it is independent of axons in vivo and continues under basal conditions in neuron-free cultures in the absence of specific P 0 -promoting signals such as cAMP elevation. In contrast, we confirm that the high P 0 mRNA and protein levels in myelin-forming cells are truly reversible and appear to depend on positive axonal signals, by showing for the first time that myelin-related P 0 levels fall rapidly to basal levels when the cells are removed from axons, even under conditions that exclude simultaneous exposure to P 0 -suppressing signals, e.g., serum in vitro or putative endoneurial inhibitory factors, such as TGFb secreted by macrophages, in vivo. Thus, the postnatal diversification of immature Schwann cells to form myelin-forming and non-myelin-forming cells involves axondependent amplification and suppression, respectively, of myelin-independent P 0 expression. In the Schwann cell lineage, this basal expression is a constitutive early phenotype that is likely to appear as one of the first signals of glial lineage choice in neural crest development.
RESULTS

The P 0 Gene Is Expressed at Basal Levels throughout Embryonic Development of the Schwann Cell Lineage
In situ experiments were carried out on whole embryos at E11 (Fig. 1A) . This revealed streams of P 0 1 cells on either side of the neural tube, forming a repeated pattern with the location and appearance characteristic of migrating neural crest cells (Erickson, 1989) . Some of the hybridized embryos were double immunolabeled with antibodies against the neuron-specific isoform of tubulin, b3, to reveal developing axons (Figs. 1B and 1C) . Observations of sections from these embryos suggested that among the crest cells, P 0 mRNA was localized selectively to clusters of cells, distributed among a larger number of P 0 -negative cells (Fig. 1B) . [This has been confirmed by double labeling with antibodies to crest-associated antigens (M.-J. Lee, unpublished).] The P 0 -positive crest cells were preferentially located near axons that are starting to grow from the neural tube at this stage, although this apparent association needs to be confirmed (Fig. 1C ).
To examine P 0 mRNA expression in Schwann cell precursors, hybridization experiments were carried out on sections from E14-15 embryos (Figs. 1D, 1E , and 1F).
A strong signal was seen in dorsal and ventral roots, within the dorsal root ganglia, and in other peripheral nerves, including those well within the developing limb. Comparison of labeling patterns in sections developed for different time periods or treated with varying probe concentrations showed that the P 0 signal was stronger and appeared earlier in dorsal and ventral roots compared with more distal nerves, indicating a proximodistal gradient in P 0 mRNA abundance (not shown). P 0 expression in embryonic Schwann cells prior to myelination was examined in sections of E17 embryos (not shown) and teased preparations of the sciatic nerve and sympathetic trunk of E18 embryos (Figs. 1G, 1H, and 1I ). An unambiguous P 0 hybridization signal was seen not only in premyelinating Schwann cells of the sciatic nerve but also in cells of the E18 sympathetic trunk although about 95% of the cells in this nerve remain non-myelin-forming in the adult. To estimate the relative strength of the P 0 hybridization signal in Schwann cell precursors and myelin-forming Schwann cells, sections of P10 sciatic nerve and E14 embryos were hybridized using a range of dilutions of the P 0 probe with all other experimental parameters constant. Probe concentrations required for clear visualization of P 0 mRNA in Postnatal Day 10 sciatic nerve sections were approximately 25-fold lower than those required to generate a strong signal in E14 nerves (not shown).
To establish a more quantitative profile of P 0 mRNA levels as precursors progress to generate embryonic Schwann cells we used semiquantitative RT-PCR (Fig.  2) . The increase in signal intensity between limb nerves in E14/15 embryos and E18 nerves was confirmed qualitatively by in situ hybridization experiments involving variable probe concentrations and color development times (not shown).
The simplest view of these experiments is that P 0 is expressed, at least at the mRNA level, throughout the embryonic development of the Schwann cell lineage from and including its origin in the neural crest, with the strength of the P 0 signal gradually increasing from E14 to the onset of myelination. While this myelinindependent P 0 mRNA expression is easily detectable and unambiguous, it is low compared to the massive expression in cells that are actively forming myelin.
Axonal Signals That Inhibit P 0 Expression
Using detection sensitivity similar to that used above to detect P 0 mRNA in embryonic nerves we now examined P 0 mRNA expression in adult nerves (Figs. 3A-3G). As expected, a very high P 0 signal was seen in myelin-forming cells, and the labeling intensity showed a positive correlation with the thickness of the myelin sheath in agreement with previous work (Griffiths et al., 1989) . Surprisingly, however, no P 0 mRNA was detected with these methods in the mature non-myelin-forming Schwann cells. These cells remained P 0 negative, both in the sciatic nerve and in the cervical sympathetic trunk, while E18 sciatic nerve and trunk processed identically gave a clear P 0 signal; similar conditions also resulted in a clear signal in nerves of E14/15 embryos. Therefore the basal P 0 gene expression seen in certain neural crest cells, Schwann cell precursors, and embryonic Schwann cells, appears to be down-regulated in adult non-myelinforming cells. To explore this further we carried out three types of nerve-transection experiments. First, the adult sympathetic trunk, which is largely unmyelinated, was transected and the cells of the distal stump examined in teased preparations 9 days later (Fig. 3H) . Immunohistochemistry with myelin basic protein (MBP) antibodies and examination by phase-contrast optics confirmed the expected disappearance of the relatively few myelin sheaths seen in normal trunks. In situ experiments showed that this was accompanied by disappearance of any cells expressing very high levels of P 0 mRNA. Surprisingly, most of the cells in the distal stump now gave a clearly detectable low level P 0 mRNA signal, comparable in intensity to that seen in the cells of trunk and sciatic nerve in E18 embryos (Figs. 3E, 3F, and 3G) . Since about 95% of the Schwann cells in normal trunks are non-myelin-forming and P 0 mRNA negative (above), this means that in non-myelin-forming cells, loss of axonal contact results in up-regulation of P 0 gene expression. Thus loss of axonal contact in vivo results in P 0 mRNA expression in myelin-forming and non-myelinforming cells moving from opposite directions toward a common basal level. The constitutive nature of this basal P 0 expression in adult Schwann cells was further indicated by finding a similar low intensity hybridization signal in the cells of the distal stump of the sciatic nerve 5 weeks after nerve transection (Figs. 3I and 3J). Finally, we observed sciatic nerves of 2-day-old rats, some of which had been transected at birth (Figs. 3K and 3L). P 0 hybridization revealed the presence of two distinct populations of P 0 -positive cells in normal 2-day nerves. There were cells with basal P 0 expression, comparable in intensity to that in E18 nerves, and cells, FIG. 2. P 0 mRNA increases with developmental age. Comparison of P 0 levels in nerve development; RT-PCR analysis. cDNA was prepared and equal amounts, quantitated relative to 18S RNA, were subjected to 42 cycles of amplification as described under Experimental Methods. Aliquots were taken after 36 and 39 cycles to ensure linear accumulation of the PCR product at this time. Individual samples corresponding to 39 cycles of amplification were electrophoresed on a 2% agarose gel containing ethidium bromide. Using shorter exposures, an increase in P 0 was observed between newborn nerves (NB) and 3-day nerves (P3). This is not evident at the exposure shown here which is necessary to show the product at E14. Relative P 0 levels between different ages were estimated by incorporation of 32 P into PCR products and quantitation by phosphorimager. A 4-to 5-fold increase was observed between precursors (E14/E15) and immature Schwann cells (E17/E18) and a further 8-to 10-fold increase by P3. not seen at E18, with much higher P 0 mRNA levels. The identity of these cells as myelin-forming cells was confirmed using MBP antibodies (not shown). Only the latter, expressing high levels of P 0 mRNA, were sensitive to loss of axonal contact: the distal stumps of 2-day-old transected nerves contained no intensely labeled cells and the bulk of the cells now showed the typical basal P 0 signal (Fig. 3L ).
Basal P 0 mRNA Expression in Pre-Myelin-Forming Cells Is Matched by a Low Level, Constitutive, P 0 Protein Expression
To test whether the basal P 0 mRNA expression could be detected at the protein level, P 0 protein expression in Schwann cell precursors, embryonic pre-myelin-forming Schwann cells, and non-myelin-forming Schwann cells in early postnatal nerves was examined immunocytochemically. The cells were plated on coverslips immediately after nerve dissociation, without any serum exposure, and fixed 3 h after plating to minimize any changes in protein expression due to removal of cells from the nerve or exposure to the culture environment. The outcome of these experiments depended on the level of sensitivity chosen for the assay, in line with what we had previously found when we examined P 0 mRNA in these cells with in situ hybridization (above). In the first set of experiments, the sensitivity was set to be similar to that used previously (e.g., Morgan et al., 1991;  low sensitivity assay, see Experimental Methods). It was found that E14 precursors and E18 cells were P 0 negative, while 2-10 and 35-45% of newborn and 4-day-old cells, respectively, were P 0 positive (not shown). Nearly all of the P 0 -positive cells from newborn and 4-day-old nerves contained myelin debris, confirming the identity of the P 0 -positive cells in this immunostaining as those making myelin in vivo. These results are in agreement with two previous studies in which P 0 antibodies were used to label myelin-forming cells in cell suspensions from newborn and 4-day-old nerves that had been dried down on coverslips prior to immunolabeling (Jessen et al., 1990; Stewart et al., 1993) . In the second set of experiments, we reasoned that since basal P 0 mRNA levels are low compared to that seen in myelin-forming cells (above), the same might hold for protein levels, and the immunohistochemical assay was therefore adjusted to a higher sensitivity (high sensitivity assay, see Experimental Methods). When this assay was applied to 3-h cultures identical to those used in the previous series of experiments, strong P 0 immunolabeling was seen not only in essentially all the Schwann cells from newborn and 4-day-old nerves, but also in most or all E14 precursors and E18 Schwann cells (Figs. 4A-4D ). Fibroblastic cells were negative in these experiments. Two experiments were undertaken to demonstrate that this P 0 expression was not the result of de novo protein synthesis occurring in response to the dissociation. First, in some experiments with newborn and E14 cells, cycloheximide (0.5 µg/ml) was included throughout the experiment to inhibit protein synthesis. This concentration promoted the survival of precursors and adversely affected Schwann cell process formation confirming effective inhibition of protein synthesis (not shown). When these cells were fixed and immunostained 3 h after plating the brightness and pattern of P 0 immunolabeling in these cells appeared indistinguishable from that seen without cycloheximide. Second, a monoclonal P 0 antibody (Archelos et al., 1993) was used to immunoblot extracts of sciatic nerves FIG. 4. P 0 protein is present in Schwann cell precursors and early Schwann cells; it is present at higher levels in extracts from early nerves than in extracts from corresponding cells in culture. (A and B) Schwann cell precursors immunolabeled with antibodies to P 0 after 3 h in culture. P 0 immunolabeling is shown in (A), while (B) shows a phase-contrast view of the same field. (C and D) Pre-myelin-forming Schwann cells from E18 sciatic nerve immunolabeled with antibodies to P 0 after 3 h in culture. Higher levels of P 0 protein are present in (C) than in (A). (D) Phase-contrast view. Bar, 12 µm. The cells in (A and C) were immunolabeled with P 0 antibodies using the high sensitivity assay (see Experimental Methods for explanation) which reveals basal levels of P 0 protein. (E) Immunoblot of extracts from E19 and newborn (NB) nerves and extracts from E19 and newborn Schwann cells cultured without any exposure to serum for 1 day in defined medium (1DIV). A band in the expected position of P 0 is present at E19 and, more intensely, in newborn nerve. The signal is higher in the nerve extracts than in the cultured cells in both E19 and newborn nerves. 2.5 µg of protein was loaded in each lane. from E19, newborn, and 4-day-old animals. In E19 nerves, prior to the onset of myelination, a distinct band was present in the expected P 0 position (27-29 kDa) (Fig.  4E) . In newborn nerves, where myelination is just beginning, a more intense band was seen in the same position, and an even heavier band was seen in 4-dayold nerves, which are actively myelinating (not shown).
To test whether basal P 0 levels were radically altered when cells were cultured for a longer time, some Schwann cells from E18 nerves were maintained in serum-free defined medium for a longer time and immunolabeled after 1 and 4 days. Examination with the sensitive assay showed that strong P 0 immunoreactivity was maintained in essentially all the cells over this time period. Comparable results were obtained with cell cultures from 1-and 4-day-old nerves (below). To test whether P 0 expression is inhibited by axonal or other signals in the nerve just before myelination (Cheng and Mudge, 1996) , we compared P 0 levels in extracts from E19 nerves to those in extracts from E19 cells 1 day after plating in serum-free medium using immunoblotting. The levels in cultured cells were found to be somewhat lower (relative to total protein) than the nerve extract; the same was found with newborn tissue (Fig. 4E) . In other experiments we verified that the standard defined medium used in these experiments does not contain factors that suppress P 0 (see below).
Taken together these results show that (1) the basal P 0 mRNA expression seen in embryonic Schwann cells prior to myelination is accompanied by basal P 0 protein expression in vivo, (2) the basal P 0 protein level, like basal P 0 mRNA, is considerably lower than that seen in myelinforming cells, even those just starting myelination, (3) basal P 0 protein levels can nevertheless be visualized as a strong, unambiguous immunolabeling of Schwann cell precursors and Schwann cells not engaged in myelination, provided the assay is adjusted to reveal relatively low P 0 levels, (4) basal P 0 protein synthesis, like basal P 0 mRNA expression, is constitutive in the sense that it continues under minimal conditions in vitro and does not depend on the presence of axons or cAMP elevating agents, and (5) basal P 0 levels in premyelin Schwann cells do not rise when they are removed from axons, as would be expected if P 0 expression in these cells was suppressed by axons.
When Myelin-Forming Cells Are Removed from Axons, High P 0 Expression Falls to Basal Levels in a Process That Does Not Depend on Active P 0 Suppression
In view of recent suggestions that the lifting of inhibitory signals, rather than positive signals from axons, may cause the up-regulation of P 0 seen at myelination, and the related idea that myelin-associated P 0 levels represent a constitutive but not an induced state (Cheng and Mudge, 1996) , we wished to establish unambiguously whether myelinating cells that were deprived of axons would maintain their high P 0 expression so long as they were free of exposure to P 0 -suppressing signals. Although in vivo experiments clearly show a dramatic and biologically relevant drop in P 0 mRNA and protein expression after nerve transection (Poduslo et al., 1985; Trapp et al., 1988) , they do not address this question since inhibitory factors such as TGFb are up-regulated in the distal stump after nerve transection (Scherer et al., 1993) . Similarly, experiments in which the drop in P 0 expression is seen when myelinating cells are isolated from axons and placed in culture have generally been carried out in medium containing serum, another effective inhibitor of P 0 expression. To examine this issue, we removed early myelinforming cells from axons and placed them in defined medium without any exposure to serum or other agents known to suppress P 0 . Immunohistochemistry, immunoblotting, Northern blotting, and semiquantitative RT-PCR were used to monitor P 0 expression. First, cells were plated on coverslips in serum-free medium, immediately after dissection from sciatic nerves of 4-day-old animals. After 3 h and 1, 2, and 4 days the cells were examined with the low-sensitivity assay to selectively label cells that were forming myelin in vivo (Figs. 5A, 5F , and 5H). At 3 h and 1 day the large majority of the P 0 -positive cells showed myelin inclusions and nearly all the cells with associated myelin debris were immunolabeled. The number of P 0 -positive cells in these experiments fell steadily over the 4-day period. When the insulin concentration in the medium was lowered 1000-fold to 5 ng/ml the same result was obtained. This was not due to selective death of myelin-forming cells, since the immunofluorescence signal gradually weakened in the cells that remained labeled; examination of the cultures with Hoechst dye failed to reveal a significant amount of apoptotic nuclei, and cell counts showed no fall in total cell number over at least 7 days, in agreement with previous work Cheng and Mudge, 1996) . Quite different results were obtained when sister cultures were labeled using the sensitive assay to examine basal P 0 expression. Now, essentially all the cells were clearly P 0 positive throughout the 4-day period (Figs. 5A, 5J , and 5K). Similar results were obtained using another well-characterized P 0 antibody (Trapp et al., 1988) (not shown). The striking fall in high-level P 0 protein expression might represent protein breakdown without alteration in P 0 gene expression at
FIG. 5.
Removal of Schwann cells from axons leads to a fall in myelin-related P 0 expression, while basal levels are relatively unaffected. (A) Counts of P 0 -positive cells at 3 h and 1-3 days following plating in serum-free medium. Some cultures were labeled with the high-sensitivity method (M) that reveals cells expressing basal levels plus cells expressing the higher myelin-related levels; the number of P 0 -positive cells in these cultures does not change. Other cultures were labeled with the low-sensitivity method (W) that selectively reveals high, myelin-related P 0 protein expression; the number of P 0 -positive cells in cultures labeled in this way falls rapidly. (B) Northern blot comparing P 0 mRNA levels in Schwann cells in freshly excised desheathed Postnatal Day 4 sciatic nerve (Day 0) with Schwann cells cultured in the absence of serum for 1 and 4 days. The mRNA level in the nerve is much higher than that in the cultured cells after 1 day in vitro. A smaller drop is seen between Days 1 and 4. 5 µg total RNA was loaded per track, and the relative amount of P 0 mRNA per track was quantitated against a cyclophilin probe using 32 P and a phosphorimager as described under Experimental Methods. The numbers above each column indicate relative amounts of P 0 mRNA in arbitrary units. (C) Semiquantitative RT-PCR comparing mRNA levels in freshly dissected desheathed nerves (NE) with cultured Schwann cells purified by immunopanning and maintained in serum-free medium for 1 or 4 days (div). The procedure is essentially as described for Fig. 2 except that the 18S control samples (21 cycles of amplification) were run together with the P 0 samples (24 cycles of amplification) to demonstrate equal loading in all tracks. The experiment was carried out using both newborn and Postnatal Day 4 nerves as indicated. Note the striking fall in the relative abundance of P 0 mRNA, although no suppressors of P 0 expression are present (longer exposure reveals the presence of basal P 0 mRNA levels at 4 days in vitro, not shown). In control experiments in which insulin was omitted with or without the addition of progesterone, T3 and T4, and dexamethasone, or the insulin level was lowered to 5 ng/ml with or without progesterone, T3 and T4, and dexamethasone, the drop in P 0 levels was not significantly altered compared with results obtained using medium containing either high insulin or alternatively 100 ng/ml IGF-1, progesterone, T3 and T4, and dexamethasone. In some experiments, immunopanned sister cultures were exposed to dbcAMP for 4 days in serum-free conditions (4 div 1 cA); this resulted in a sharp increase in the relative abundance of P 0 mRNA. (D and E) Bright-field micrographs showing P 0 revealed by in situ hybridization in newborn Schwann cells cultured in defined medium for 1 and 7 days. In the 1-day culture those cells about to myelinate show much higher levels of P 0 than others, whereas by 7 days these heavily labeled cells are no longer visible and all cells contain basal P 0 levels. Bar, 24 µm. (F, G, H, and I) P 0 protein in cultured Schwann cells from Postnatal Day 4 rats; low-sensitivity labeling after 1 and 4 days in culture. A typical field from a 1-day culture shows two large myelin-forming cells. P 0 -negative cells, not engaged in myelin formation (arrows), are clearly seen in the accompanying phase-contrast micrograph (G). By 4 days in culture most brightly labeled cells have disappeared, as shown in the typical field in the fluorescence micrograph (H) and accompanying phase-contrast micrograph (I). (J and K) P 0 protein in cultured Schwann cells from Postnatal Day 4 rats; high-sensitivity labeling after 1 and 4 days in culture. Note that at both 1 day (J) and 4 days (K) of culture nearly all the cells are brightly labeled. The arrow points to a Schwann cell that had been making myelin in vivo. (F-K) Bar, 12 µm. the mRNA level. We therefore examined P 0 mRNA by in situ hybridization using a DIG-labeled probe in cultures from newborn nerves that were plated and maintained for 7 days as described above (Figs. 5D and 5E ). A strong signal was obtained from 25-35% of the cells after 1 day in vitro, while the rest of the cells showed weak labeling corresponding to basal P 0 expression. As with high protein expression, the number of cells with a high mRNA signal fell radically during the culture period. To demonstrate that this reflected a selective reduction in P 0 mRNA, we measured the relative abundance of P 0 mRNA using Northern blots and semiquantitative RT-PCR. The experiments were carried out on RNA from newborn and 4-day-old nerves and on cells plated immediately from nerves of newborn and 4-day-old animals purified by immunopanning and maintained at high density in serum-free medium for 1 and 4 days (Figs. 5B and 5C). Quantitation of the Northern blots from Postnatal Day 4 animals showed that after 4 days in serum-free medium in vitro, the relative abundance of P 0 mRNA was 5-10% of that in nerve extracts. This reflects a selective depletion of P 0 mRNA, since the same amount of total RNA was applied to the gel for each of the three experimental conditions. Similar results were seen in the RT-PCR assay using nerves and cultured cells from newborn and 4-day-old nerves. The defined medium used in these experiments contained 5 µg of insulin, sufficient to stimulate type 1 IGF receptors, or alternatively IGF-1, and progesterone, dexamethasone, triiodothyronine (T3), and thyroxine (T4). Although all of these components have previously been shown either to promote myelination directly or to enhance the synthesis of myelin proteins, including P 0 (Warringa et al., 1987; Barakat-Walter et al., 1992; Tosic et al., 1992; Koenig et al., 1995; Stewart et al., 1996) , we nevertheless carried out control experiments from which these components were absent to further exclude any inhibitory signaling that might affect P 0 expression. The use of this simple medium did not affect the drop in P 0 mRNA levels as assayed by semiquantitative RT-PCR (not shown).
Together, these experiments show that in myelinforming Schwann cells the relative abundance of P 0 mRNA and expression of P 0 protein both fall radically to basal levels when the cells are removed from contact with axons, even in the complete absence of any factors known to suppress P 0 expression. The basal levels, in contrast, continue to be expressed in the routine serumfree medium employed in these experiments and are, in this sense, constitutive.
Many previous studies indicate that an axonal signal that up-regulates P 0 expression in myelin-forming cells might act in part by elevating intracellular cAMP (for Refs. see Discussion). It has recently been suggested, however, that elevation of cAMP has little or no effect on raising P 0 protein levels in cells that have never been cultured in serum (Cheng and Mudge, 1996) . We therefore tested the effect of cAMP elevation on cells from newborn and 4-day-old nerves that were never exposed to serum or other factors that suppress P 0 expression. The cells were purified by immunopanning and maintained for 3 days in defined medium with or without the cAMP analogue dibutyryl cAMP (dbcAMP). P 0 mRNA levels were then measured by semiquantitative RT-PCR and compared to those for the 18S ribosomal subunit as described previously. This revealed a sharp increase in the relative abundance of P 0 mRNA in the cells exposed to the cAMP analogue (Fig. 5C ).
DISCUSSION
We show here that in the rat, constitutive, basal expression of the P 0 gene can, using sensitive methods, be traced back as far as the neural crest. We found no evidence for P 0 expression outside cells of the peripheral glial lineage. Thus, P 0 is likely to represent one of the earliest markers of glial differentiation in both mammalian and avian neural crest (Barbu, 1990; Bhattacharyya et al., 1991; Zhang et al., 1995) . Therefore the massive P 0 expression in myelin-forming cells represents an axoninduced amplification of preexisting basal levels rather than new gene activation. We also show that signals that inhibit P 0 are not required for the sharp reduction in P 0 mRNA and protein expression that follows removal of myelin-forming Schwann cells from axons. Our experiments suggest, however that inhibitory signals have a role in the development of non-myelin-forming cells in vivo (Mews and Meyer, 1993) .
By combining in vivo and in vitro observations it is now possible to distinguish three broad categories of P 0 expression (Fig. 6 ): (I) High, induced levels in cells forming myelin; (II) lower, but clearly detectable levels seen early in development in some neural crest cells, in Schwann cell precursors, and in early Schwann cells and in cultured cells; this basal level is constitutive in the sense that it is present in denervated Schwann cells in vivo and in Schwann cells cultured under minimal conditions without inhibitory signaling molecules; and (III) suppressed levels seen in mature non-myelinforming cells in vivo and in cells cultured with P 0 inhibitory signals such as serum, NDFb, TGFb, or FGF. This model accords with previous findings. These include the rapid rise in P 0 mRNA that occurs at the onset of myelination and its rapid fall on denervation (Lemke and Axel, 1985; Trapp et al., 1988; Stahl et al., 1990) and the basal levels of P 0 and MBP that exist in adult Schwann cells deprived of axonal contact and the P 0 mRNA that persists in cultured neonatal cells (Poduslo et al., 1985; LeBlanc and Poduslo, 1990; Morgan et al., 1991; Morrison et al., 1991) . It also accords with the finding that mouse Schwann cells continue to express low levels of P 0 protein in vitro in the absence of myelin assembly (Burroni et al., 1988) and the similar observation made more recently in the rat (Cheng and Mudge, 1996) . The existence of significant P 0 expression in the Schwann cell lineage throughout embryonic development, its suppression in mature non-myelin-forming cells, and its reappearance on denervation indicates that P 0 might have a role in development and regeneration that is separate from its function in the myelin sheath (D'Urso et al., 1990; Filbin et al., 1990; SchneiderSchaulies et al., 1990) . Our observations also suggest that the P 0 promoter might contain regions responsible for three distinct expression patterns: up-regulation, downregulation, and basal expression that is lineage specific and activated early in development.
The Role of Positive Signals in Myelin-Related P 0 Expression
Although both P 0 protein and mRNA can be used to study whether axonal signals positively regulate the P 0 gene, observations at the mRNA level are more direct, and therefore more reliable, than examination of the amount of accumulated protein, since this is likely to be subject to additional controls, for instance relating to membrane spiraling and compaction. We observed an unequivocal fall in the relative abundance of P 0 mRNA (in addition to a fall in P 0 protein) when extracts from 4-day-old nerves were compared to cells from similar nerves after 1-4 days in serum-free medium in vitro. An even greater drop is likely if we had used nerves at the peak of myelination (Stahl et al., 1990 ) and the drop is also likely to be a quantitative underestimation because of the inevitable dilution of the nerve mRNA by perineurial cells and fibroblasts. This is a selective fall in P 0 mRNA, since the same amount of total mRNA was used for each of the experimental situations in the Northern blots, and the cDNA was normalized to representative invariant mRNAs in the RT-PCR experiments. While these findings are in line with previous work (LeBlanc and Poduslo, 1990; Lemke and Chao, 1988; Trapp et al., 1988; Thomson et al., 1993) they are important nevertheless, since they discriminate between two different reasons for the drop in P 0 mRNA: (i) that it occurs because of negative signals (e.g., TGFb) in cut nerves or in serum-containing medium that suppresses P 0 expression, as implied by Cheng and Mudge (1996) , or (ii) that it is a response to the removal of positive signals that are needed to induce and maintain high level (as distinct from basal, constitutive) P 0 gene expression. The present finding of a fall in P 0 mRNA of some 10-fold in the absence of signals that suppress P 0 expression supports the latter alternative and provides strong evidence for the idea that during active myelination the very high amounts of P 0 mRNA, relative to total mRNA, in myelin-forming cells depend on positive signals in the nerve, presumably associated with the myelinated axons.
cAMP and P 0 Expression
The molecular identity of this putative axonal signal and the pathways it activates in Schwann cells are largely unknown. While several reports show that cAMP elevation mimics axonal signals in the sense that cAMP elevates P 0 expression (Lemke and Chao, 1988; Morgan et al., 1991; Kamholz et al., 1992; Mews and Meyer, 1993) , it has been pointed out that these experiments might be hard to interpret because of the use of serum (Cheng and Mudge, 1996) . The present work shows that it remains true that agents that elevate or mimic intracellular cAMP stimulate P 0 expression, particularly the relative abundance of P 0 mRNA, in Schwann cells that have never been exposed to serum (Fig. 5) . cAMP-induced P 0 elevation shows similarities with axonally elevated P 0 expression during myelination; for instance, both are suppressed by TGFb and in both cases there is a strong negative correlation between cells synthesizing DNA and cells induced to express very high P 0 levels (Morgan et al., 1991) [the basal, constitutive P 0 expression found in all Schwann cells other than mature non-myelin-forming cells is, of course, compatible with proliferation (Cheng and Mudge, 1996) ]. Elevation of cAMP also induces several other changes in Schwann cells that are thought to be signaled by axons during nerve development (Scherer and Saltzer, 1995) . It is, however, unlikely that cAMP alone operates a master switch that triggers myelin differentiation; for instance, cAMP-induced P 0 expression does not quantitatively match P 0 levels in myelin-forming cells, and high P 0 expression with concomitant down-regulation of N-CAM, P75NGFr, and GFAP is generally only seen in a proportion of the cells in each culture exposed to cAMP-elevating agents (Morgan et al., 1991) . Until more conclusive experiments are devised, cAMP remains a candidate mediator of some of the axonal signals that induce (Lemke and Chao, 1988) or maintain (Poduslo et al., 1995) Schwann cell differentiation.
Is P 0 Expression Suppressed Prior to Myelination?
Schwann cell DNA synthesis peaks sharply at E18-E19 (Stewart et al., 1993) and evidence suggests that this proliferation is substantially driven by NDF (Morrisey et al., 1995) , perhaps in association with FGF (Dong et al., 1995) , both of which suppress P 0 protein levels in cultured cells. We therefore looked for such suppression in vivo. We found, however, that E18 and newborn cells showed P 0 immunolabeling that was stronger than that in E14 precursors when these cells were examined with the sensitive method after 3 h in vitro and that this was not affected by inhibiting new protein synthesis during the cell dissociation and 3-h plating period. Immunoblotting also failed to detect an increase in P 0 protein when E19 or newborn cells were removed from axonal contact and placed in serum-free medium; similarly we detected a fall rather than a rise in P 0 mRNA when cultured cells were compared with newborn nerves by RT-PCR (Figs. 4 and 5) . We have suggested previously that P 0 expression in developing nerves reflects a balance between positive and negative signals . The present experiments indicate that in the immediate premyelination period the net inhibitory effect resulting from such interactions must be small since removal of the cells from the nerve results in a small decrease in P 0 protein (Fig. 4E) , rather than the increase that might be expected if the cells were being released from strong inhibitory signaling. This contrasts with the clear inhibition of P 0 mRNA during the postnatal maturation of non-myelin-forming cells.
EXPERIMENTAL METHODS
Materials
Sources of materials used in cell culture, in situ hybridization, immunocytochemistry, and Western blotting have been detailed in previous papers Jessen et al., 1994; Dong et al., 1995; Stewart et al., 1996) .
Monoclonal antibody to MBP was from Boehringer Mannheim. Goat anti-mouse Ig or anti-rabbit Ig conjugated to fluorescein were from Cappel Organon Teknika Corp. Cross-reactivity to rabbit or mouse Ig, respectively, was removed by adsorption against rabbit or mouse Ig's. The OX7 hybridoma cell line producing mouse monoclonal anti-Thy1.1 antibody was from the European Collection of Animal Cell Cultures. Monoclonal mouse antibody 192 IgG, recognizing the p75 NGF receptor, was a gift from Dr. E. Johnson Jr. Rabbit antibody to P 0 was prepared in this laboratory using a modification of the method of Brockes et al. (1980) . The antibody was absorbed against skin and treated with caprylic acid to remove nonspecific labeling as described previously (Stewart et al., 1996) . Monoclonal antibody to P 0 was a gift from Dr. J. J. Archelos (Archelos et al., 1993) , and polyclonal P 0 antibody was a gift from Dr. B. D. Trapp (Trapp et al., 1988) . Monoclonal antibody TUJ1, recognizing the b3 isoform of tubulin (Moody et al., 1987) , was a gift from Dr. A. Frankfurter. Rabbit anti-mouse IgG was from Dako Immunoglobulins a/s. SYBR green was from Molecular Probes, Inc. Ultraspec RNA isolation reagent was from Biotecx Laboratories, Inc. Random hexamers and Superscript II reverse transcriptase were from BRL. Taq polymerase was from Promega, Inc. Microspin S300 columns were from Pharmacia Biotechnology, Inc.
Polyester Wax Sections
Whole embryos (plug day is E0) from SpragueDawley rats were fixed in phosphate-buffered 4% paraformaldehyde (pH 7.4) at room temperature for 4 h (E11), 6 h (E14), and overnight (E17 or older) and embedded in polyester wax (Steedman, 1957) .
Seven-to 10-µm sections were dewaxed in methanol for 2 3 20 min or until clear, dried for at least 20 min, then taken through graded ethanols for 2 min each. They were then washed in PBS for 2 3 5 min before in situ hybridization.
Denervation of Nerves and Teased Nerve Preparations
Left sciatic nerves or cervical sympathetic trunks were cut and teased essentially as described previously (Jessen et al., 1985 (Jessen et al., , 1987 . The teased nerves were air dried for 10 min, fixed in phosphate-buffered paraformaldehyde (pH 7.4) for 2 h, dehydrated, air dried, and used immediately or stored at 270°C.
In Situ Hybridization of Wax Sections, Teased Nerves, Cultures, and Whole-Mount Embryos
For DIG labeling of sections, teased nerves, and cultures, a cDNA (SN63c) encoding the entire P 0 coding sequence (1.8 kb) subcloned into pGEM4, donated by Drs. G. Lemke and I. Griffiths, was used essentially as described previously (Lemke and Axel, 1985; Griffiths et al., 1989; Morgan et al., 1994) . DIG-labeled probes were transcribed using the Boehringer SP6/T7 transcription kit and manufacturer's instructions. Transcripts were hydrolyzed to give an average probe length of 150 bases and the probe was used at varying concentrations. Color development of hybridized probe was carried out over a period of 1-4 days.
For whole-mount embryos modification of the method of Wilkinson was used (1992) . RNAse treatment was omitted and the embryos were then hybridized for 40 h at 50°C in the hybridization mix containing heatdenatured P 0 probe.
Combined Immunolabeling and in Situ Hybridization of Sections, Teased Nerves, and Whole Embryos
For teased nerves and sections, in situ hybridization was carried out as described above until the DIG antibody step. MBP labeling was coupled with in situ hybridization to reveal myelinated fibers. MBP (1:800) antibodies were incubated together with DIG antibody in 0.1% Triton and 1% dried milk in buffer 3 (BoehringerMannheim) overnight at 4°C. For MBP, tissues or teased nerve preparations were then incubated with antimouse Ig biotin for 30 min and streptavidin-fluorescein for 15 min. They were then incubated with color solution as previously described.
For whole embryos, in situ hybridization was carried out as described above, but the NBT/X-phosphate color precipitation was developed to an extremely deep blue color before being fixed in 4% paraformaldehyde for 20 min. The embryos were then washed in PBS for 2 3 5 min, dehydrated through graded ethanols, mounted in polyester wax, and sectioned. To visualize axon outgrowth occurring at the same time as neural crest migration, sections were postimmunolabeled with antibodies to b-tubulin (1:400) overnight and goat antimouse Ig fluorescein (1:100) for 30 min.
Schwann Cell Culture
The defined medium used in this study has been described previously and is a modification of the medium of Bottenstein and Sato . In some experiments, IGF-1 (100 ng/ml) was substituted for insulin (5 µg/ml) or the insulin concentration was lowered to 5 ng/ml. In control experiments for the RT-PCR experiments involving comparison of mRNA levels in intact nerves and cultured immunopanned cells, low insulin (5 ng/ml) or no insulin was substituted for high insulin, and dexamethasone, progesterone, T3, and T4 were omitted from the medium.
Schwann cells from E18, Postnatal Day 0, Postnatal Day 4, and adult sciatic nerves and brachial plexus or adult cervical sympathetic trunk were desheathed and dissociated as described previously . In contrast to previous experiments serum was not used to neutralize the enzymes used in the dissociation procedure and no serum was used at other stages in the preparation of the cells. Five milliliters of defined medium was used to dilute out the enzymes, and after centrifugation cells were resuspended in defined medium and plated onto laminin-coated coverslips or petri dishes or were immunopanned prior to plating.
In some experiments Schwann cells were purified by immunopanning, using a modification of the method previously developed for DRG neurons (Dong et al., 1995) . Freshly dissociated cells (10 6 ) from newborn or Postnatal Day 4 rats prepared as described above were resuspended in 6-7 ml of defined medium and the suspension was transferred to a dish coated with Thy1.1 antibodies for 10 min exactly. After shaking vigorously the cells were left for a further 8-10 min and the nonadherent cells removed. They were then transferred to a second dish coated in the same way and left again for 10 min. At this stage few cells adhered to the dish. The nonadherent cells were again removed, pelleted, resuspended in defined medium , counted, and plated either onto laminin-coated coverslips (2500 cells in 20-µl drop) or onto 35-mm-diameter laminin-coated tissue culture plastic dishes (6 3 10 5 cells total) for Northern blotting, immunoblotting, and RT-PCR analysis. After 3-4 days in culture in defined medium the Schwann cells were 99.5 6 0.42% pure, compared with 86.8 6 2.46% for unpurified cells, as judged by immunolabeling with antibodies to p75NGF receptor.
Induction of P 0
Freshly dissociated Schwann cells from rats of various ages were plated out in defined medium for periods of 3 h to 7 days. In some experiments, 4 µM forskolin or 1 mM dbcAMP was added to the medium at 3 h, 20 h, or later times, as specified. At 24 and 48 h after the first addition the medium was changed and fresh 4 µM forskolin or 100 µM dbcAMP added. The experiment was normally terminated at 72 h after the first addition.
RT-PCR
Total RNA was made from sciatic nerves and brachial plexus freshly dissected from E14, 15, 16, and 18 and Postnatal Day 0, 1, and 3 rats using the Ultraspec RNA isolation reagent. In other experiments total RNA was made from immunopanned Schwann cells that were prepared from newborn and Postnatal Day 4 rats and plated in tissue culture plastic dishes as described above. RNA (250 ng) was reverse transcribed into cDNA using random hexamers as primer and Superscript II reverse transcriptase as recommended in the manufacturer's protocol. The synthesis of equal amounts of cDNA from each sample was confirmed by PCR amplification using specific primers for 18S RNA, followed by agarose gel electrophoresis and ethidium bromide staining (see below) (Owens and Boyd, 1991) . Equal amounts of cDNA (equivalent to 10 ng of total RNA) were used for PCR with the oligonucleotide primer pairs described by Brunden et al. (1992) for P 0 . Each cycle was 94°C 1 min, 52°C 1 min, and 72°C 1 min. The number of cycles used is described in the figure legends. One-fifth of each reaction was electrophoresed on a 4% polyacrylamide or 2% agarose gel and stained with ethidium bromide. Where quantitation of PCR products was required, 1 Ci [ 32 P]dCTP was included in the reaction and after electrophoresis gels were dried and exposed to a FUJI BAS 1000 imaging plate for 1 h and bands were scanned and quantitated using a FUJI BAS 1000 phosphorimager.
Northern Blotting
Total RNA was prepared as described above. Five micrograms of total RNA was separated on a 1.2% agarose gel under standard denaturing conditions and transferred onto Hybond-N membrane. Equal RNA loading was confirmed by ethidium bromide staining and Polaroid photography. Single-stranded [ 32 P]dCTPlabeled antisense DNA probes of 181 nt (P 0 ) and 298 nt (cyclophilin) were generated by PCR using a P 0 or a cyclophilin cDNA containing plasmid (G. Zoidl, unpublished result) as a template for the amplification reaction (Hannon et al., 1993) . Amplification products were purified on Microspin S-300 columns, diluted in hybridization buffer (0.5 M Na 2 HPO 4 , 7% SDS, pH 7.3) to a specific activity of approximately 2 3 10 6 cpm/ml, and subjected to hybridization at 65°C for up to 16 h. Membranes were washed at a final stringency of 0.13 SSC/0.1% SDS at 65°C for 30 min and exposed to X-ray film. A quantitative evaluation of P 0 and cyclophilin mRNA levels was performed on a phosphorimager as described above.
Immunoblotting
Proteins from desheathed sciatic nerves from E19 and Postnatal Day 0 and 4 rats and from Schwann cells cultured for 24 h in defined medium were extracted and subjected to SDS-polyacrylamide gel electrophoresis using a 12% acrylamide slab gel. They were then immunoblotted using monoclonal antibodies to P 0 (1:10,000) and a Vectastain Elite kit. The signal was visualized by chemiluminescence (ECL kit) as described previously .
Immunolabeling of Cell Cultures
Cells were immunolabeled with antibodies to P 0 using two different regimes, chosen either to reveal high P 0 levels in myelin-forming Schwann cells but not the basal levels seen in other Schwann cells (low sensitivity assay) or to reveal basal P 0 levels in precursors, in immature Schwann cells, and in cells without axonal contact (high-sensitivity assay). These two alternatives were chosen by immunolabeling of Schwann cells from newborn nerves after 20 h in culture in defined medium. In both cases cells were prefixed, as described previously, in 2 M HCl for 10 min, which gives optimal labeling with our antibody . In the first case (low-sensitivity labeling) the cells were incubated with antibodies to P 0 diluted 1:1000 or 1:1500 with antibody-diluting solution for 2 h at room temperature, washed, and further incubated with goat anti-rabbit fluorescein Ig, preabsorbed with mouse Ig, diluted 1:200 in antibody-diluting solution for 0.5 h. This dilution of antibody gives labeling comparable to that used in many of our previous studies. In the second case (high-sensitivity labeling) basal levels were revealed by choosing a concentration of the P 0 antibodies at which .90% of cells were labeled in the 20-h culture. In this case, referred to as sensitive labeling, the cells were incubated with antibodies to P 0 diluted 1:200 or 1:400 overnight at 4°C, washed, and then incubated with goat anti-rabbit fluorescein Ig as above. There was no labeling of fibroblastic cells under either of these conditions.
